반려동물 건강 및 웰니스 시장 예측(-2034년) : 제품 유형, 서비스 유형, 반려동물 종류, 유통 채널, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Pet Health and Wellness Market is accounted for $271.9 billion in 2026 and is expected to reach $553.8 billion by 2034 growing at a CAGR of 9.3% during the forecast period. Pet health and wellness encompasses products and services designed to maintain and improve the physical and mental health of companion animals. The market encompasses product types including veterinary pharmaceuticals, nutritional supplements, diagnostic products, dental care products, skin and coat care products, joint and mobility products, digestive health products, and behavioral and mental wellness products. Service types include veterinary care, preventive veterinary services, diagnostic services, telehealth and digital veterinary services, and pet rehabilitation and physiotherapy. Growing pet humanization, increasing awareness of pet health, and expanding veterinary services are key drivers of market expansion.

Market Dynamics:

Driver:

Growing awareness of pet health and preventive care

The increasing awareness among pet owners of the importance of preventive care and early detection of health issues is a primary driver for the pet health and wellness market. Pet owners are increasingly seeking regular veterinary check-ups, vaccinations, and preventive treatments. Awareness of nutrition's role in pet health is growing. Early detection and treatment of health conditions improves outcomes and reduces long-term costs. As pet owners prioritize health and wellness, demand for products and services expands, supporting sustained market growth.

Restraint:

High costs of veterinary care and limited insurance coverage

The significant costs associated with veterinary pharmaceuticals, diagnostics, and advanced treatments and limited pet insurance coverage represent a major restraint for the market. Advanced veterinary treatments can be expensive. Pet insurance penetration remains low in many regions. Cost concerns may lead pet owners to delay or forgo treatments. These cost barriers may constrain market growth, particularly for advanced care.

Opportunity:

Expansion of telehealth and digital veterinary services

The growing adoption of telehealth and digital veterinary services presents significant opportunities for pet health and wellness market expansion. Remote consultations improve access to veterinary expertise. Digital monitoring tools enable continuous health tracking. Online pharmacies expand access to medications. As digital health adoption grows, these services capture growing market share.

Threat:

Competition from alternative and home remedies

Competition from alternative therapies and home remedies poses significant threats to the pet health and wellness market. Some pet owners may prefer natural or homemade remedies. Alternative treatments may compete with conventional veterinary care. Price sensitivity may drive DIY approaches. This competition may limit market growth for professional products and services.

Covid-19 Impact:

The COVID-19 pandemic accelerated pet health and wellness market growth as pet owners prioritized health and spent more time with their animals. Demand for preventive care and health products increased. Telehealth services expanded significantly. E-commerce sales of pet health products grew. Post-pandemic, continued health focus has supported market growth.

The Veterinary Pharmaceuticals segment is expected to be the largest during the forecast period

The Veterinary Pharmaceuticals segment is expected to account for the largest market share during the forecast period, driven by the essential role of medications in treating and preventing disease in companion animals. Veterinary pharmaceuticals include antibiotics, parasiticides, anti-inflammatories, and other medications. The segment benefits from continuous innovation and expanding treatment options. As pet owners seek advanced care, pharmaceuticals maintain the largest product type segment share.

The Telehealth and Digital Veterinary Services segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Telehealth and Digital Veterinary Services segment is predicted to witness the highest growth rate, fueled by growing adoption of remote consultations, increasing smartphone penetration, and demand for convenient access to veterinary care. Telehealth enables remote consultations and monitoring. The segment benefits from technology advancements and changing consumer preferences. As digital health adoption accelerates, telehealth delivers the fastest service type segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership, strong spending on pet health, and advanced veterinary infrastructure. The United States leads regional growth with substantial investment in pet health. High awareness of preventive care drives demand. Well-established veterinary networks support market accessibility. With high spending and advanced care, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing disposable incomes, and growing awareness of pet health across China, India, Japan, and Southeast Asia. The region's rapidly growing pet population creates substantial demand. Increasing veterinary infrastructure supports market expansion. As pet health awareness grows, Asia Pacific delivers the fastest pet health and wellness market growth globally.

Key players in the market

Some of the key players in Pet Health and Wellness Market include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Ceva Sante Animale, Virbac S.A., Vetoquinol S.A., Dechra Pharmaceuticals PLC, Mars, Incorporated, Nestle Purina PetCare, Hill's Pet Nutrition, Inc., Nutramax Laboratories, Inc., Zesty Paws, PetIQ, LLC, and Covetrus, Inc.

Key Developments:

In September 2026, Boehringer Ingelheim Animal Health expanded veterinary preventative care and infectious disease monitoring programs across Europe.

In June 2026, Merck Animal Health entered into a definitive agreement to acquire TARGAN, integrating automated vision-guidance and biological delivery technologies into its portfolio.

In June 2026, Ceva Sante Animale acquired Spanish biotechnology firm Aquilon CyL S.L. to strengthen its animal microbiome research, gut health products, and preventative formulations.

In December 2025, Elanco Animal Health announced plans at its Investor Day to expand R&D and manufacturing investments in the U.S., highlighting an accelerated USDA review pathway for a novel companion animal immunotherapeutic.

Product Types Covered:

• Veterinary Pharmaceuticals
• Nutritional Supplements
• Diagnostic Products
• Dental Care Products
• Skin and Coat Care Products
• Joint and Mobility Products
• Digestive Health Products
• Behavioral and Mental Wellness Products

Service Types Covered:

• Veterinary Care
• Preventive Veterinary Services
• Diagnostic Services
• Telehealth and Digital Veterinary Services
• Pet Rehabilitation and Physiotherapy

Pet Types Covered:

• Dogs
• Cats
• Birds
• Other Companion Animals

Distribution Channels Covered:

• Veterinary Clinics and Hospitals
• Pet Specialty Stores
• Pharmacies and Drugstores
• Online Retail
• Other Distribution Channels

End Users Covered:

• Pet Owners
• Veterinary Practices
• Pet Care Facilities
• Animal Shelters and Rescue Organizations

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Health and Wellness Market, By Product Type

• 5.1 Veterinary Pharmaceuticals
• 5.2 Nutritional Supplements
• 5.3 Diagnostic Products
• 5.4 Dental Care Products
• 5.5 Skin and Coat Care Products
• 5.6 Joint and Mobility Products
• 5.7 Digestive Health Products
• 5.8 Behavioral and Mental Wellness Products

6 Global Pet Health and Wellness Market, By Service Type

• 6.1 Veterinary Care
• 6.2 Preventive Veterinary Services
• 6.3 Diagnostic Services
• 6.4 Telehealth and Digital Veterinary Services
• 6.5 Pet Rehabilitation and Physiotherapy

7 Global Pet Health and Wellness Market, By Pet Type

• 7.1 Dogs
• 7.2 Cats
• 7.3 Birds
• 7.4 Other Companion Animals

8 Global Pet Health and Wellness Market, By Distribution Channel

• 8.1 Veterinary Clinics and Hospitals
• 8.2 Pet Specialty Stores
• 8.3 Pharmacies and Drugstores
• 8.4 Online Retail
• 8.5 Other Distribution Channels

9 Global Pet Health and Wellness Market, By End User

• 9.1 Pet Owners
• 9.2 Veterinary Practices
• 9.3 Pet Care Facilities
• 9.4 Animal Shelters and Rescue Organizations

10 Global Pet Health and Wellness Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Zoetis Inc.
• 13.2 Elanco Animal Health Incorporated
• 13.3 Boehringer Ingelheim International GmbH
• 13.4 Merck & Co., Inc.
• 13.5 Ceva Sante Animale
• 13.6 Virbac S.A.
• 13.7 Vetoquinol S.A.
• 13.8 Dechra Pharmaceuticals PLC
• 13.9 Mars, Incorporated
• 13.10 Nestle Purina PetCare
• 13.11 Hill's Pet Nutrition, Inc.
• 13.12 Nutramax Laboratories, Inc.
• 13.13 Zesty Paws
• 13.14 PetIQ, LLC
• 13.15 Covetrus, Inc.